CDCA3 and neoplasm: Collectively, these findings indicated that CDCA3 expression modulated the immune escape and immunosuppressive effects and regulated the tumor-infiltrating immune cells in the tumor progression, thereby demonstrating its potential as a prognostic biomarker for HCC.